PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1876563
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1876563
The Global Soft Robotics for Medical Applications Market was valued at USD 96.9 million in 2024 and is estimated to grow at a CAGR of 19.6% to reach USD 601.3 million by 2034.

The market growth is primarily driven by rapid advancements in materials science and robotics technology. The development of soft materials such as elastomers, hydrogels, and shape-memory polymers has enabled the creation of flexible and biocompatible robotic devices that can safely interact with the human body. These materials allow the robots to adapt to body contours, improving patient comfort and minimizing the risk of injury. When integrated with advanced sensors, soft robotic systems can monitor muscle activity, pressure, and joint movement in real time, enhancing precision in therapy and enabling personalized rehabilitation. This technological evolution is expanding the use of soft robotics in medical procedures, wearable health devices, rehabilitation tools, and implantable systems. The rise of telemedicine, remote monitoring, and patient-centered care is further promoting the use of soft robotic technologies to enhance recovery, mobility, and long-term well-being.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $96.9 Million |
| Forecast Value | $601.3 Million |
| CAGR | 19.6% |
The wearable medical devices are gaining immense popularity for continuous health tracking and remote therapy. Soft robotics is revolutionizing this segment by delivering more adaptable, lightweight, and comfortable wearables that support rehabilitation, assist movement, and promote better sleep quality. Devices designed for home use, such as robotic gloves and exosuits, are enabling patients with limited mobility or neurological disorders to undergo therapy independently. Integration with digital applications and cloud-based systems ensures real-time monitoring, data sharing, and personalized treatment adjustments. With growing awareness around patient independence and convenience, wearable soft robotic solutions are becoming a vital part of modern healthcare systems.
The exoskeleton segment held a 63.5% share in 2024. The increasing number of individuals with mobility challenges, coupled with rising cases of trauma and age-related movement disorders, is fueling this segment's expansion. Soft robotic exoskeletons replicate the body's natural movements by using advanced sensors and actuators, helping users regain the ability to walk, stand, and perform rehabilitative exercises. Their flexible, lightweight structure makes them suitable for various settings, including hospitals, home care environments, and rehabilitation centers.
The home care settings segment held a 49.3% share in 2024. The adoption of soft robotics in home-based rehabilitation is transforming patient recovery by offering convenient and affordable care solutions. Devices designed for home use focus on user comfort and ease of operation while allowing remote supervision by healthcare providers. Such technologies help reduce hospital visits and enhance overall recovery outcomes, empowering patients to manage therapy independently in familiar surroundings.
North America Soft Robotics for Medical Applications Market held 52.6% share in 2024 and is projected to continue leading throughout the forecast period. The region's dominance is supported by its advanced healthcare infrastructure, significant investment in R&D, and early adoption of robotic and assistive technologies. A growing elderly population and the increasing prevalence of chronic conditions are driving demand for rehabilitation and assistive robotic systems, further strengthening regional market growth.
Prominent players in the Global Soft Robotics for Medical Applications Market include BIOSERVO, HUNIC, MyoSwiss, OnRobot, Roceso Technologies, SYREBO, SIFSOF, Somnox, and SRT. Companies in the Soft Robotics for Medical Applications Market are focusing on product innovation, technological collaboration, and clinical validation to strengthen their market position. Many are investing in the development of biocompatible materials and sensor-integrated systems that enhance safety, comfort, and adaptability in medical use. Strategic partnerships with hospitals, research institutions, and rehabilitation centers are helping expand real-world applications and adoption rates. Firms are also prioritizing miniaturization and wireless connectivity to improve usability in wearable and home care devices.